Equine Anti-Thymocyte Globulin
Sponsors
National Cancer Institute (NCI), Massachusetts General Hospital, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions
Acute Liver FailureAcute Liver InjuryAmyloidosisFulminant Hepatic FailureGATA2Hepatic EncephalopathyImmune DysregulationImmunodeficiency
Phase 2
Pilot and Feasibility Study of Reduced-Intensity Hematopoietic Stem Cell Transplant for MonoMAC
CompletedNCT00923364
Start: 2009-05-07End: 2017-02-26Updated: 2020-03-12
Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations
RecruitingNCT01861106
Start: 2013-07-24End: 2028-12-31Target: 144Updated: 2026-03-24
TReatment for ImmUne Mediated PathopHysiology
RecruitingNCT04862221
Start: 2022-02-09End: 2027-02-01Target: 163Updated: 2026-03-10